Edition:
United Kingdom

United Therapeutics Corp (UTHR.OQ)

UTHR.OQ on NASDAQ Stock Exchange Global Select Market

139.53USD
18 Jan 2018
Change (% chg)

-- (--)
Prev Close
$139.53
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
192,743
52-wk High
$169.58
52-wk Low
$112.15

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 3.48 December 19 Jan 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 0 0 0 0
(3) HOLD 6 6 6 6
(4) UNDERPERFORM 3 3 3 3
(5) SELL 2 2 2 2
No Opinion 0 0 0 0
Mean Rating 3.23 3.23 3.23 3.23

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 5 358.75 405.21 322.00 --
Quarter Ending Jun-18 5 347.02 393.64 314.86 --
Year Ending Dec-18 13 1,366.82 1,493.63 1,140.63 1,452.01
Earnings (per share)
Quarter Ending Mar-18 5 3.48 4.20 2.68 --
Quarter Ending Jun-18 5 3.22 4.04 2.78 --
Year Ending Dec-18 11 11.49 12.47 10.62 12.32
LT Growth Rate (%) 2 -23.19 -16.70 -29.68 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 426.43 445.50 19.07 4.47
Quarter Ending Jun-17 391.53 444.60 53.07 13.55
Quarter Ending Mar-17 399.59 370.50 29.09 7.28
Quarter Ending Dec-16 415.51 409.00 6.50 1.57
Quarter Ending Sep-16 402.35 408.20 5.85 1.45
Earnings (per share)
Quarter Ending Sep-17 3.85 6.27 2.42 62.68
Quarter Ending Jun-17 3.65 4.40 0.75 20.70
Quarter Ending Mar-17 3.50 3.89 0.39 11.04
Quarter Ending Dec-16 3.61 2.49 1.12 31.11
Quarter Ending Sep-16 3.34 3.50 0.16 4.95

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 358.75 347.14 347.14 311.84 --
Quarter Ending Jun-18 347.02 335.36 335.14 305.60 --
Year Ending Dec-18 1,366.82 1,347.06 1,346.42 1,300.12 1,452.01
Earnings (per share)
Quarter Ending Mar-18 3.48 3.16 3.16 3.03 --
Quarter Ending Jun-18 3.22 2.89 2.89 2.79 --
Year Ending Dec-18 11.49 11.32 11.31 11.08 12.32

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 0 0
Quarter Ending Jun-18 0 0 1 0
Year Ending Dec-18 1 0 2 0
Earnings
Quarter Ending Mar-18 1 0 1 0
Quarter Ending Jun-18 1 0 2 0
Year Ending Dec-18 1 0 2 0